5 Einträge gefunden

1. Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

   1. Nagler, Arnon
   2. Peczynski, Christophe
   3. Dholaria, Bhagirathbhai
   4. Labopin, Myriam
   5. Valerius, Thomas
   6. Dreger, Peter
   7. Kröger, Nicolaus

   2022 - Forschungsinformationssystem des UKE
2. Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

   1. Nagler, Arnon
   2. Peczynski, Christophe
   3. Dholaria, Bhagirathbhai
   4. Labopin, Myriam
   5. Valerius, Thomas
   6. Dreger, Peter
   7. Kröger, Nicolaus

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosis

   1. Gagelmann, Nico
   2. Wolschke, Christine
   3. Salit, Rachel B
   4. Schroeder, Thomas
   5. Ditschkowski, Markus
   6. Panagiota, Victoria
   7. Cassinat, Bruno

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Isatuximab, Carfilzomib, Lenalidomid und Dexamethason (Isa-KRd) in der Erstlinientherapie des Hochrisiko Multiplen Myeloms: Interimanalyse der GMMG-CONCEPT Studie, Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial

   1. Leypoldt, Lisa B.
   2. Besemer, Britta
   3. Asemissen, Anne Marie
   4. Hänel, Mathias
   5. Blau, Igor Wolfgang
   6. Görner, Martin
   7. Ko, Yon-Dschun

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis

   1. McLornan, D
   2. Eikema, D J
   3. Czerw, T
   4. Kröger, N
   5. Koster, L
   6. Reinhardt, Hans Christian
   7. Angelucci, E

   2021 - Forschungsinformationssystem des UKE